Emma Pendleton Bradley Hospital

Emma Pendleton Bradley Hospital, doing business as Bradley Hospital, is a non-profit pediatric psychiatric research and treatment organization based in Riverside, Rhode Island, that operates as a prime recipient and subrecipient on federal research grants focused on child and adolescent mental health, sleep science, and behavioral health outcomes. The organization does not hold federal contracts but maintains an active federal grant portfolio across the National Institutes of Health (NIH), the Health Resources and Services Administration (HRSA), and the Substance Abuse and Mental Health Services Administration (SAMHSA), positioning itself as a research-intensive academic medical institution.

Bradley Hospital's grant footprint centers on pediatric psychiatry research, sleep and circadian rhythm science, and early intervention studies for children exposed to adversity. As a prime recipient, the hospital leads 56 of 93 total awards (60%), with the remainder distributed across 37 subrecipient arrangements with universities and state health departments. The National Institute of Mental Health (NIMH) dominates the customer concentration, accounting for 27 awards covering internalizing disorders, OCD treatment augmentation with transcranial magnetic stimulation, depressive symptoms in autism spectrum disorder, and suicidal behavior prevention in sexual minority youth. The National Institute of Child Health and Human Development (NICHD) and the National Institute on Drug Abuse (NIDA) round out the top funding agencies, with HRSA providing substantial support for school-based mental health infrastructure and home visiting programs. Combined obligated dollars across all awards reach $149.8 million.

Recent prime grant activity includes a $7.94 million NIH Construction Support award (CFDA 93.352) effective September 2025 through May 2030 to build the Bradley Hospital Integrative Research Laboratories, a 13,856 square-foot research facility consolidating pediatric psychiatry research groups with specialized sleep and circadian research suites, biomarker assessment laboratories, and neuromodulation capabilities. A $368,500 NIMH Project Grant (CFDA 93.242) awarded May 2026 investigates mitochondrial signaling and stress-induced physiological changes in children ages 9–12 with internalizing disorders using cell-free mitochondrial DNA as a novel biomarker. A $164,516 NICHD Project Grant (CFDA 93.865) awarded October 2025 supports longitudinal analysis of pediatric irritability trajectories and convergent validity across measurement modalities in a diverse maltreatment-exposed cohort. Additional representative prime work includes an NIMH R61/R33 award testing repetitive transcranial magnetic stimulation augmentation of exposure and response prevention for pediatric obsessive-compulsive disorder, and a five-year SAMHSA Project AWARE grant (effective September 2022 through September 2027) developing school-based mental wellness infrastructure across three Rhode Island school districts serving 35,447 students annually.

Subrecipient work shows deep collaborative ties to Brown University (sleep assessment protocols, suicidal ideation interviews with young children, maternal-child interaction measurement), Butler Hospital (ecological assessment of suicide risk during care transitions), and state health agencies including the Rhode Island Department of Health (pediatric mental health access, youth suicide prevention, home visiting programs) and Rhode Island Department of Human Services (early care and education consultation for behavioral health promotion). Bradley Hospital researchers serve in advisory, recruitment, and assessment roles, with documented expertise in sleep physiology, circadian rhythm measurement, trauma-informed intervention implementation, and pediatric psychiatric phenotyping.

Activity grew substantially from 2022 (7 awards) to 2024 (21 awards), with a decline in 2025–2026 (9 and 5 awards respectively). Thirteen awards face ultimate completion within the next twenty-four months, representing potential recompete and renewal opportunity across NIMH, NICHD, and HRSA grant programs. The organization's research strategy emphasizes mechanistic investigation of transdiagnostic risk factors—stress physiology, sleep disruption, emotion regulation, and biological aging—in high-risk youth populations, positioning Bradley Hospital as a specialized research site for pediatric behavioral health outcomes and implementation science in school and community settings.